Nā huahana
-
ʻO ka Antigen ʻili o ka maʻi Hepatitis B (HBsAg)
Hoʻohana ʻia ka pahu hana no ka ʻike qualitative o ka hepatitis B virus surface antigen (HBsAg) i loko o ke serum kanaka, plasma a me ke koko holoʻokoʻa.
-
ʻŌnaehana ʻIke Molekala Akomi ʻo Eudemon™ AIO800
ʻEudemonaTMʻO ka ʻōnaehana ʻike molekala aunoa AIO800 i lako me ka magnetic bead extraction a me ka ʻenehana PCR fluorescent he nui hiki ke ʻike koke a pololei i ka waikawa nucleic i loko o nā laʻana, a hoʻomaopopo maoli i ka hōʻailona molekala lapaʻau "Laʻana i loko, pane i waho".
-
Hoʻohui ʻia ʻo HIV Ag/Ab
Hoʻohana ʻia ka pahu hana no ka ʻike ʻana i ka antigen HIV-1 p24 a me ka antibody HIV-1/2 i loko o ke koko holoʻokoʻa o ke kanaka, serum a me ka plasma.
-
Pahu ʻIke wikiwiki no ka HIV 1/2 Ab (Colloidal Gold)
Hoʻohana ʻia ka pahu hana no ka ʻike ʻana i ka antibody HIV (HIV1/2) i loko o ke koko holoʻokoʻa o ke kanaka, ka serum a me ka plasma.
-
15 ʻAno o ka Human Papillomavirus E6/E7 Gene mRNA kiʻekiʻe-pilikia
Kuhi ʻia kēia pahu hana no ka ʻike ʻana i 15 mau pae hoʻopuka mRNA gene human papillomavirus (HPV) E6/E7 kiʻekiʻe i loko o nā pūnaewele i exfoliated o ka cervix wahine.
-
28 ʻAno o ka maʻi papilloma kanaka kiʻekiʻe (16/18 Typing) Nucleic Acid
Nā palapala hōʻoia: CE, Vietnam MDA, TFDA, AMMPS
He kūpono kēia pahu no ka ʻike ʻana i ka qualitative in vitro o 28 mau ʻano o nā maʻi papilloma kanaka (HPV) (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nucleic acid i loko o ka mimi kāne/wahine a me nā pūnaewele exfoliated cervical wahine. Hiki ke ʻano ʻia ka HPV 16/18, ʻaʻole hiki ke ʻano ʻia nā ʻano i koe, e hāʻawi ana i kahi ala kōkua no ka ʻike ʻana a me ka mālama ʻana i ka maʻi HPV.
-
28 ʻAno o ka HPV Nucleic Acid Detection Kit (Fluorescence PCR)
Kōmike Huahana
HWTS-CC003
ʻAe ʻia ka huahana
CE
Hoʻohana ʻia ke kime no ka ʻike ʻana i nā ʻano 28 o ka maʻi papilloma kanaka (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) o nā waikawa nucleic i loko o ka mimi kanaka, ka ʻili ʻana o ka ʻōpū wahine a me nā ʻili ʻana o ka ʻōpū wahine, akā ʻaʻole hiki ke hoʻokaʻawale piha ʻia kēia mau maʻi papilloma kanaka. Hiki iā ia ke hāʻawi wale i nā mea kōkua no ka ʻike ʻana a me ka mālama ʻana i ka maʻi HPV.
-
Ke ʻano o ka hoʻohālikelike ʻana o ka maʻi papilloma kanaka (28 ʻano)
ʻAe ʻia ka huahana
CE, Serbia MoH, TFDA, AMMPS
Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka qualitative a me ka genotyping o ka nucleic acid o 28 mau ʻano o ka human papillomavirus (HPV6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) i loko o ka mimi kāne/wahine a me nā pūnaewele exfoliated cervical wahine, e hāʻawi ana i nā mea kōkua no ka ʻike a me ka mālama ʻana i ka maʻi HPV.
-
ʻO ka Enterococcus kū'ē i ka Vancomycin a me ka Gene kū'ē i ka lāʻau lapaʻau
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka vancomycin-resistant enterococcus (VRE) a me kāna mau genes kūʻē i nā lāʻau lapaʻau ʻo VanA a me VanB i loko o ka sputum kanaka, ke koko, ka mimi a i ʻole nā kolone maʻemaʻe.
-
ʻO ka Polymorphism Gene CYP2C9 kanaka a me VKORC1
He kūpono kēia pahu hana no ka ʻike ʻana i ka polymorphism o CYP2C9*3 (rs1057910, 1075A>C) a me VKORC1 (rs9923231, -1639G>A) ma ka DNA genomic o nā hāpana koko holoʻokoʻa kanaka.
-
ʻO ka Polymorphism Gene CYP2C19 kanaka
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka polymorphism o nā genes CYP2C19 CYP2C19*2 (rs4244285, c.681G>A), CYP2C19*3 (rs4986893, c.636G>A), CYP2C19*17 (rs12248560, c.806>T) i loko o ka DNA genomic o nā hāpana koko holoʻokoʻa kanaka.
-
ʻAkika Nucleic B27 Leukocyte kanaka
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka DNA ma nā ʻano antigen leukocyte kanaka HLA-B*2702, HLA-B*2704 a me HLA-B*2705.
